Role of bile acids in inflammatory liver diseases
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in the control of immune regulation and on effects of pharmacological modulators of bile acid signaling pathways in human liver disease. Recent mouse studies have highlighted the importance of the interactions between bile acids and gut microbiome. Interfering with microbiome composition may be beneficial for cholestatic and metabolic liver diseases by modulating formation of secondary bile acids, as different bile acid species have different signaling functions. Bile acid receptors such as FXR, VDR, and TGR5 are expressed in a variety of cells involved in innate as well as adaptive immunity, and specific microbial bile acid metabolites positively modulate immune responses of the host. Identification of Cyp2c70 as the enzyme responsible for the generation of hydrophilic mouse/rat-specific muricholic acids has allowed the generation of murine models with a human-like bile acid composition. These novel mouse models will aid to accelerate translational research on the (patho)physiological roles of bile acids in human liver diseases .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Their enterohepatic circulation allows them to act as hormones by stimulating nuclear receptors such as FXR in the gut and liver,40”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
Self-citationLoomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Bile acid metabolites control TH17 and Treg cell differentiation
Hang, S., Paik, D., Yao, L., Kim, E., Trinath, J., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1785-z · Cited by 1,457
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)33041-7 · Cited by 1,277
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Song, X., Sun, X., Oh, S. F., Wu, M., Zhang, Y., Zheng, W., Geva-Zatorsky, N., Jupp, R., Mathis, D., Benoist, C., et al. (2020) · Nature · doi:10.1038/s41586-019-1865-0 · Cited by 1,024
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
The interaction of hepatic lipid and glucose metabolism in liver diseases
Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamisligil, G. S., Trauner, M., & Canbay, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.025 · Cited by 994
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Campbell, C., McKenney, P. T., Konstantinovsky, D., Isaeva, O. I., Schizas, M., Verter, J., Mai, C., Jin, W.-B., Guo, C.-J., Violante, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2193-0 · Cited by 901
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
Jiao, N., Baker, S. S., Chapa-Rodriguez, A., Liu, W., Nugent, C. A., Tsompana, M., Mastrandrea, L., Buck, M. J., Baker, R. D., Genco, R. J., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314307 · Cited by 737
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Bile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634
Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.005 · Cited by 576
Plasma Metabolomic Profile in Nonalcoholic Fatty Liver Disease
Kalhan, S. C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A. J., Hanson, R. W., & Milburn, M. (2011) · Metabolism · doi:10.1016/j.metabol.2010.03.006 · Cited by 532
Banales, J. M., Huebert, R. C., Karlsen, T., Strazzabosco, M., LaRusso, N. F., & Gores, G. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0125-y · Cited by 517
Bile Acids Induce Inflammatory Genes in Hepatocytes
Allen, K., Jaeschke, H., & Copple, B. L. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.026 · Cited by 501
Molecular physiology of bile acid signaling in health, disease, and aging
Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481
Wang, Y.-D., Chen, W.-D., Yu, D., Forman, B. M., & Huang, W. (2011) · Hepatology · doi:10.1002/hep.24525 · Cited by 480
Govaere, O., Cockell, S., Tiniakos, D., Queen, R., Younes, R., Vacca, M., Alexander, L., Ravaioli, F., Palmer, J., Petta, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba4448 · Cited by 479
Bile acids in glucose metabolism in health and disease
Shapiro, H., Kolodziejczyk, A. A., Halstuch, D., & Elinav, E. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171965 · Cited by 464
Role of bile acids in metabolic control
Molinaro, A., Wahlström, A., & Marschall, H.-U. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.002 · Cited by 447
Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids
Haeusler, R. A., Astiarraga, B., Camastra, S., Accili, D., & Ferrannini, E. (2013) · Diabetes · doi:10.2337/db13-0639 · Cited by 444
Bile Acids as Metabolic Regulators and Nutrient Sensors
Chiang, J. Y. L., & Ferrell, J. M. (2019) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082018-124344 · Cited by 437
Jansen, P. L. M., Strautnieks, S. S., Jacquemin, E., Hadchouel, M., Sokal, E. M., Hooiveld, G. J. E. J., Koning, J. H., de Jager-Krikken, A., Kuipers, F., Stellaard, F., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70287-8 · Cited by 433
Self-citationPuri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology · doi:10.1002/hep.29359 · Cited by 426
Bile Acids and Metabolic Regulation
Staels, B., & Fonseca, V. A. (2009) · Diabetes Care · doi:10.2337/dc09-s355 · Cited by 415
Lee, G., You, H. J., Bajaj, J. S., Joo, S. K., Yu, J., Park, S., Kang, H., Park, J. H., Kim, J. H., Lee, D. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18754-5 · Cited by 395
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Mouzaki, M., Wang, A. Y., Bandsma, R., Comelli, E. M., Arendt, B. M., Zhang, L., Fung, S., Fischer, S. E., McGilvray, I. G., & Allard, J. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151829 · Cited by 385
Hofmann, A. F., & Hagey, L. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r049437 · Cited by 358
Fifty years of advances in bile acid synthesis and metabolism
Russell, D. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800026-jlr200 · Cited by 358
Beuers, U., Hohenester, S., de Buy Wenniger, L. J. M., Kremer, A. E., Jansen, P. L. M., & Elferink, R. P. J. O. (2010) · Hepatology · doi:10.1002/hep.23810 · Cited by 351
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs
Ahmad, T. R., & Haeusler, R. A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0266-7 · Cited by 337
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Ferslew, B. C., Xie, G., Johnston, C. K., Su, M., Stewart, P. W., Jia, W., Brouwer, K. L. R., & Sidney Barritt, A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3776-8 · Cited by 335
Worthmann, A., John, C., Rühlemann, M. C., Baguhl, M., Heinsen, F.-A., Schaltenberg, N., Heine, M., Schlein, C., Evangelakos, I., Mineo, C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4357 · Cited by 318
Self-citationCyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans
Takahashi, S., Fukami, T., Masuo, Y., Brocker, C. N., Xie, C., Krausz, K. W., Wolf, C. R., Henderson, C. J., & Gonzalez, F. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m071183 · Cited by 313
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
Adams, D. H., & Eksteen, B. (2006) · Nature Reviews Immunology · doi:10.1038/nri1784 · Cited by 307
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H.-U., Altorjay, I., Färkkilä, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.009 · Cited by 297
Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.001 · Cited by 289
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kowdley, K. V., Luketic, V., Chapman, R., Hirschfield, G. M., Poupon, R., Schramm, C., Vincent, C., Rust, C., Parés, A., Mason, A., et al. (2018) · Hepatology · doi:10.1002/hep.29569 · Cited by 281
Bile acids and their receptors in metabolic disorders
Fiorucci, S., Distrutti, E., Carino, A., Zampella, A., & Biagioli, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101094 · Cited by 258
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
Tanaka, N., Matsubara, T., Krausz, K. W., Patterson, A. D., & Gonzalez, F. J. (2012) · Hepatology · doi:10.1002/hep.25630 · Cited by 249
Bechmann, L. P., Kocabayoglu, P., Sowa, J.-P., Sydor, S., Best, J., Schlattjan, M., Beilfuss, A., Schmitt, J., Hannivoort, R. A., Kilicarslan, A., et al. (2013) · Hepatology · doi:10.1002/hep.26225 · Cited by 233
Verbeke, L., Farre, R., Verbinnen, B., Covens, K., Vanuytsel, T., Verhaegen, J., Komuta, M., Roskams, T., Chatterjee, S., Annaert, P., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.009 · Cited by 225
Poupon, R. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(12)70015-3 · Cited by 222
Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition
Honda, A., Miyazaki, T., Iwamoto, J., Hirayama, T., Morishita, Y., Monma, T., Ueda, H., Mizuno, S., Sugiyama, F., Takahashi, S., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000395 · Cited by 213
Bile acid levels are increased in the liver of patients with steatohepatitis
Aranha, M. M., Cortez-Pinto, H., Costa, A., da Silva, I. B. M., Camilo, M. E., de Moura, M. C., & Rodrigues, C. M. P. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f4710a · Cited by 211
Hepatic injury induced by bile salts: Correlation between biochemical and morphological events
Schmucker, D. L., Ohta, M., Kanai, S., Sato, Y., & Kitani, K. (1990) · Hepatology · doi:10.1002/hep.1840120523 · Cited by 207
Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D., Reily, M. D., Lu, Z., Lehman-McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189
Nimer, N. A., Choucair, I., Wang, Z., Nemet, I., Li, L., Gukasyan, J., Weeks, T. L., Alkhouri, N., Zein, N. N., Tang, W. H. W., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154457 · Cited by 164
Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors
Shin, D., & Wang, L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_236 · Cited by 149
Alterations of the bile microbiome in primary sclerosing cholangitis
Liwinski, T., Zenouzi, R., John, C., Ehlken, H., Rühlemann, M. C., Bang, C., Groth, S., Lieb, W., Kantowski, M., Andersen, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318416 · Cited by 149
Self-citationGut microbiome and bile acids in obesity-related diseases
Li, R., Andreu-Sánchez, S., Kuipers, F., & Fu, J. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101493 · Cited by 147
Self-citationUnderstanding bile acid signaling in diabetes: From pathophysiology to therapeutic targets
Ferrell, J. M., & Chiang, J. Y. L. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0043 · Cited by 139
Schmitt, J., Kong, B., Stieger, B., Tschopp, O., Schultze, S. M., Rau, M., Weber, A., Müllhaupt, B., Guo, G. L., & Geier, A. (2015) · Liver International · doi:10.1111/liv.12456 · Cited by 135
Steiner, C., Othman, A., Saely, C. H., Rein, P., Drexel, H., von Eckardstein, A., & Rentsch, K. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025006 · Cited by 132
Activation of necroptosis in human and experimental cholestasis
Afonso, M. B., Rodrigues, P. M., Simão, A. L., Ofengeim, D., Carvalho, T., Amaral, J. D., Gaspar, M. M., Cortez-Pinto, H., Castro, R. E., Yuan, J., et al. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.280 · Cited by 130
Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
Chen, R., Hou, W., Zhang, Q., Kang, R., Fan, X.-G., & Tang, D. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00099 · Cited by 129
Dasarathy, S., Yang, Y., McCullough, A. J., Marczewski, S., Bennett, C., & Kalhan, S. C. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328345c8c7 · Cited by 124
Liu, H., Pathak, P., Boehme, S., & Chiang, J. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069807 · Cited by 123
Straniero, S., Laskar, A., Savva, C., Härdfeldt, J., Angelin, B., & Rudling, M. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000307 · Cited by 121
Species differences in bile acids I. Plasma and urine bile acid composition
Thakare, R., Alamoudi, J. A., Gautam, N., Rodrigues, A. D., & Alnouti, Y. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3644 · Cited by 112
Brown adipose tissue and lipid metabolism
Heeren, J., & Scheja, L. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000504 · Cited by 111
Self-citationReduced oncotic necrosis in fas receptor-deficient C57BL/6J- lpr mice after bile duct ligation
Gujral, J. S., Liu, J., Farhood, A., & Jaeschke, H. (2004) · Hepatology · doi:10.1002/hep.1840400431 · Cited by 109
Interactions between bile salts, gut microbiota, and hepatic innate immunity
Schubert, K., Olde Damink, S. W. M., von Bergen, M., & Schaap, F. G. (2017) · Immunological Reviews · doi:10.1111/imr.12579 · Cited by 105
Beuers, U., Spengler, U., Zwiebel, F. M., Pauletzki, J., Fischer, S., & Paumgartner, G. (1992) · Hepatology · doi:10.1002/hep.1840150409 · Cited by 102
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
Legry, V., Francque, S., Haas, J. T., Verrijken, A., Caron, S., Chávez-Talavera, O., Vallez, E., Vonghia, L., Dirinck, E., Verhaegen, A., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01397 · Cited by 101
Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors
Keitel, V., Stindt, J., & Häussinger, D. (2019) · Handbook of Experimental Pharmacology · doi:10.1007/164_2019_230 · Cited by 98
Chen, L., van den Munckhof, I. C. L., Schraa, K., ter Horst, R., Koehorst, M., van Faassen, M., van der Ley, C., Doestzada, M., Zhernakova, D. V., Kurilshikov, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108212 · Cited by 91
Self-citationThe xenobiotic receptors PXR and CAR in liver physiology, an update
Cai, X., Young, G. M., & Xie, W. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166101 · Cited by 84
CAR directs T cell adaptation to bile acids in the small intestine
Chen, M. L., Huang, X., Wang, H., Hegner, C., Liu, Y., Shang, J., Eliason, A., Diao, H., Park, H., Frey, B., et al. (2021) · Nature · doi:10.1038/s41586-021-03421-6 · Cited by 84
Review: Pathogenesis of cholestatic liver diseases
Yokoda, R. T., & Rodríguez, E. A. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i8.423 · Cited by 81
Vesterhus, M., & Karlsen, T. H. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01681-z · Cited by 80
Bjursell, M., Wedin, M., Admyre, T., Hermansson, M., Böttcher, G., Göransson, M., Lindén, D., Bamberg, K., Oscarsson, J., & Bohlooly-Y, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064721 · Cited by 77
New insights in the multiple roles of bile acids and their signaling pathways in metabolic control
de Boer, J. F., Bloks, V. W., Verkade, E., Heiner-Fokkema, M. R., & Kuipers, F. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000508 · Cited by 76
Self-citationAltered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis
Suga, T., Yamaguchi, H., Ogura, J., Shoji, S., Maekawa, M., & Mano, N. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114664 · Cited by 73
de Boer, J. F., de Vries, H. D., Palmiotti, A., Li, R., Doestzada, M., Hoogerland, J. A., Fu, J., Rose, A. M. L., Westerterp, M., Mulder, N. L., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.12.004 · Cited by 69
Self-citationFerrell, J. M., Pathak, P., Boehme, S., Gilliland, T., & Chiang, J. Y. L. (2019) · Hepatology · doi:10.1002/hep.30513 · Cited by 65
Terasaki, S., Nakanuma, Y., OGINO, H., Unoura, M., & KOBAYASHI, K. P. (1991) · PubMed · Cited by 63
Sturm, E., Havinga, R., Baller, J. F. W., Wolters, H., van Rooijen, N., Kamps, J. A. A. M., Verkade, H. J., Karpen, S. J., & Kuipers, F. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.019 · Cited by 60
Self-citationGurantz, D., Schteingart, C. D., Hagey, L. R., Steinbach, J. H., Grotmol, T., & Hofmann, A. F. (1991) · Hepatology · doi:10.1002/hep.1840130323 · Cited by 58
Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis
Roberts, S. B., Ismail, M., Kanagalingam, G., Mason, A. L., Swain, M. G., Vincent, C., Yoshida, E. M., Tsien, C., Flemming, J. A., Janssen, H. L. A., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1518 · Cited by 58
Accumulation of macrophages in primary sclerosing cholangitis
Cameron, R., Blendis, L. M., & Neuman, M. G. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00215-6 · Cited by 54
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis
Raselli, T., Hearn, T., Wyss, A., Atrott, K., Peter, A., Frey-Wagner, I., Spalinger, M. R., Maggio, E. M., Sailer, A. W., Schmitt, J., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093229 · Cited by 48
Cholestasis induces major histocompatibility complex class I expression in hepatocytes
Calmus, Y., Arvieux, C. C., Gane, P., Boucher, E., Nordlinger, B., Rouger, P., & Poupon, R. Y. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90778-w · Cited by 47
Obeticholic acid for the treatment of primary biliary cholangitis
Ali, A. H., & Lindor, K. D. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1218471 · Cited by 47
Nishigaki, Y., Ohnishi, H., Moriwaki, H., & Muto, Y. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088577 · Cited by 46
Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis
Glaser, F., John, C., Engel, B., Hoeh, B., Weidemann, S. A., Dieckhoff, J., Stein, S., Becker, N., Casar, C., Schuran, F. A., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.030 · Cited by 42
Self-citationMicrobiome Modulation of the Host Adaptive Immunity through Bile Acid Modification
Kuipers, F., de Boer, J. F., & Staels, B. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.006 · Cited by 42
Self-citationStellaard, F., Sackmann, M. F., Berr, F., & Paumgartner, G. (1987) · Journal of Mass Spectrometry · doi:10.1002/bms.1200141106 · Cited by 36
Podevin, P., Calmus, Y., Bonnefis, M. T., Veyrunes, C., Chéreau, C., & Poupon, R. Y. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90219-8 · Cited by 35
Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation
Gujral, J. S., Liu, J., Farhood, A. I., et al. (2004) · Hepatology · doi:10.1002/hep.20380 · Cited by 32
Increased intercellular adhesion molecule-1 serum concentration in cholestasis
Polzien, F., & Ramadori, G. P. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80292-3 · Cited by 28
Zou, M., Wang, A., Wei, J., Cai, H., Yu, Z., Zhang, L., & Wang, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107328 · Cited by 24
Koopman, B. J., Kuipers, F., Bijleveld, C. M. A., van der Molen, J. C., Nagel, G. T., Vonk, R. J., & Wolthers, B. G. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90004-6 · Cited by 17
Self-citationBile Acid Look-Alike Controls Life Span in C. elegans
Groen, A. K., & Kuipers, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.07.009 · Cited by 13
Self-citationWu, L. Y. (1988) · PubMed · Cited by 1
Cited by
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
TNF in the liver: targeting a central player in inflammation
Tiegs, G., & Horst, A. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00910-2 · Cited by 224
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Jiao, T., Ma, Y., Guo, X., Ye, Y., & Xie, C. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00880-z · Cited by 136
Mechanism of action of the bile acid receptor TGR5 in obesity
Lun, W., Yan, Q., Guo, X., Zhou, M., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.011 · Cited by 129
Metadata
- Authors
- Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- University Medical Center Groningen (NL)
- Venue
- Seminars in Immunopathology
- Published
- 2021-07-08
- Volume
- 43
- Issue
- 4
- Pages
- 577-590
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- PMC
- PMC8443512
- OpenAlex
- W3179865180
- Cited by
- 121
- References
- 107
- Citations by year
- 2026: 23 · 2025: 24 · 2024: 23 · 2023: 23 · 2022: 23 · 2021: 5
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Seminars in Immunopathology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB841)
- ICIN Netherlands Heart Institute (DCVA grant 2018-27)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- bile acids, bile acid signaling, inflammatory liver disease, cholestatic liver disease, metabolic liver disease, gut microbiota, secondary bile acids, farnesoid X receptor, vitamin D receptor, TGR5, immune regulation, muricholic acids, humanized mice, bile acid receptors
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bile Acids and Salts, Humans, Liver, Liver Diseases, Signal Transduction, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.